FDA Approved: ZURZUVAE — Supplemental Application (Biogen MA Inc.)

View source ↗

Summary

The FDA approved a supplemental application for Zurzuvae (zuranolone) from Biogen MA Inc., resulting in an updated label under the supplemental submission.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Postpartum Depression

Drugs mentioned

• ZURZUVAE (ZURANOLONE)

Snippet

SUPPL AP for ZURZUVAE (ZURANOLONE)